Cite Filings / AGIO / 0001193125-18-121025
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

AGIOS PHARMACEUTICALS, INC. · Filed 2018-04-18 · Acc 0001193125-18-121025

Documents 1

  • DEF 14A Proxy Statement , d513033ddef14a.htm

Around this filing

  • 2019-04-18 DEF 14A Proxy Statement
  • 2018-04-25 4 Chief Commercial Officer sold 2,050 shares at $85.95 ($176,198)
  • 2018-04-18 DEFA14A Proxy Materials
  • 2018-04-18 DEF 14A Proxy Statement
  • 2018-04-16 4 Chief Medical Officer sold 2,000 shares at an average $85.10 ($170,190)
  • 2018-04-13 8-K Material agreement · New debt or obligation
  • 2017-04-24 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d513033ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…